2026-2030年全球寡核苷酸合成市场

全球寡核苷酸合成市场预计在 2025 年至 2030 年间将成长 55.936 亿美元，预测期内复合年增长率为 17.8%。

本报告对全球寡核苷酸合成市场进行了全面分析，包括市场规模和预测、趋势、成长要素和挑战，以及对约 25 家公司的供应商分析。

本报告对当前市场状况、最新趋势和驱动因素以及整体市场环境进行了最新分析。市场成长的驱动因素包括寡核苷酸合成方法的技术进步、对基于寡核苷酸的疗法的需求不断增长以及投资和策略合作的激增。

本研究采用客观的方法，结合一手和二手讯息，包括来自主要行业相关人员的意见。报告包含全面的市场规模数据、区域細項分析、供应商格局以及对主要企业的分析。报告提供历史数据和预测数据。

研究强调，向酶合成和永续合成方法的转变是未来几年推动全球寡核苷酸合成市场成长的主要因素之一。寡核苷酸在治疗和精准医疗领域应用范围的不断扩大，以及高通量和自动化合成平台的日益普及，预计将显着提升市场需求。

目录

第一章执行摘要

第二章 Technavio 分析

• 价格、生命週期、顾客购买篮、采用率和购买标准分析
• 投入与差异化因素的重要性
• 混淆来源
• 驱动因素和挑战的影响

第三章 市场情势

• 市场生态系统
• 市场特征
• 价值链分析

第四章 市场规模

• 市场定义
• 市场区隔分析
• 2025年市场规模
• 2025-2030年市场展望

第五章 市场规模表现

• 2020-2024年全球寡核苷酸合成市场
• 应用细分市场分析 2020-2024
• 2020-2024年最终用户细分市场分析
• 2020-2024年产品细分市场分析
• 2020-2024年区域市场分析
• 2020-2024年国家细分市场分析

第六章 定性分析

• 人工智慧的影响：寡核苷酸合成的全球市场

第七章五力分析

• 五力分析概述
• 买方的议价能力
• 供应商的议价能力
• 新进入者的威胁
• 替代品的威胁
• 竞争威胁
• 市场状况

第八章 按应用进行市场细分

• 比较：按应用
• PCR引子
• PCR检测与试剂盒
• DNA微阵列
• 萤光原位杂合反应
• 其他的
• 按应用分類的市场机会

9. 按最终用户进行市场区隔

• 比较：按最终用户
• 製药和生物技术公司
• 研究和学术机构
• 诊断检查室
• 医院
• 按最终用户分類的市场机会

第十章 按产品进行市场细分

• 比较：按产品
• 寡核苷酸产品
• 试剂和耗材
• 合成器
• 按产品分類的市场机会

第十一章 客户情况

第十二章 区域情势

• 区域细分
• 区域比较
• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 荷兰
• 亚洲
  • 中国
  • 印度
  • 日本
  • 韩国
  • 泰国
  • 印尼
• 世界其他地区
  • 巴西
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 以色列
  • 南非
  • 土耳其
  • 阿根廷
  • 哥伦比亚
• 各区域的市场机会

第十三章：驱动因素、挑战与机会

• 市场驱动因素
• 市场挑战
• 驱动因素和挑战的影响
• 市场机会

第十四章 竞争格局

• 概述
• 竞争格局
• 令人困惑的局面
• 产业风险

第十五章 竞争分析

• 公司简介
• 企业排名指数
• 公司市场定位
• Agilent Technologies Inc.
• Ajinomoto Bio Pharma Services
• Ansa Biotechnologies
• Azenta Inc.
• Bio Synthesis Inc
• Biogen Inc.
• Biotage AB
• Danaher Corp.
• GenScript Biotech Corp.
• Kaneka Corp.
• Merck KGaA
• Nitto Denko Corp.
• QIAGEN NV
• Synbio Technologies LLC
• Thermo Fisher Scientific Inc.

第十六章附录

The global oligonucleotide synthesis market is forecasted to grow by USD 5593.6 mn during 2025-2030, accelerating at a CAGR of 17.8% during the forecast period. The report on the global oligonucleotide synthesis market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements in oligonucleotide synthesis methods, escalating demand for oligonucleotide-based therapeutics, surging investments and strategic collaborations.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global oligonucleotide synthesis market is segmented as below:

By Application

• PCR primers
• PCR assays and panels
• DNA microarrays
• Fluorescence in situ hybridization
• Others

By End-User

• Pharmaceutical and biotechnology companies
• Research and academic institutes
• Diagnostic laboratories
• Hospitals

By Product

• Oligonucleotide products
• Reagents and consumables
• Synthesis equipment

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the shift toward enzymatic and sustainable synthesis methods as one of the prime reasons driving the global oligonucleotide synthesis market growth during the next few years. Also, expansion of oligonucleotide applications in therapeutics and precision medicine and increasing adoption of high-throughput and automated synthesis platforms will lead to sizable demand in the market.

The report on the global oligonucleotide synthesis market covers the following areas:

• Global oligonucleotide synthesis market sizing
• Global oligonucleotide synthesis market forecast
• Global oligonucleotide synthesis market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global oligonucleotide synthesis market vendors that include Agilent Technologies Inc., Ajinomoto Bio Pharma Services, Ansa Biotechnologies, Azenta Inc., Bio Synthesis Inc, Biogen Inc., Biotage AB, Danaher Corp., GenScript Biotech Corp., Kaneka Corp., LGC Ltd., Merck KGaA, Nitto Denko Corp., QIAGEN N.V., Synbio Technologies LLC, Syngene International Ltd., Thermo Fisher Scientific Inc., Twist Bioscience Corp., WuXi AppTec Co. Ltd.. Also, the global oligonucleotide synthesis market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Oligonucleotide Synthesis Market 2020 - 2024
  • Historic Market Size - Data Table on Global Oligonucleotide Synthesis Market 2020 - 2024 ($ million)
• 5.2 Application segment analysis 2020 - 2024
  • Historic Market Size - Application Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Oligonucleotide Synthesis Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Application

• 8.1 Market segments
• 8.2 Comparison by Application
• 8.3 PCR primers - Market size and forecast 2025-2030
• 8.4 PCR assays and panels - Market size and forecast 2025-2030
• 8.5 DNA microarrays - Market size and forecast 2025-2030
• 8.6 Fluorescence in situ hybridization - Market size and forecast 2025-2030
• 8.7 Others - Market size and forecast 2025-2030
• 8.8 Market opportunity by Application
  • Market opportunity by Application ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Pharmaceutical and biotechnology companies - Market size and forecast 2025-2030
• 9.4 Research and academic institutes - Market size and forecast 2025-2030
• 9.5 Diagnostic laboratories - Market size and forecast 2025-2030
• 9.6 Hospitals - Market size and forecast 2025-2030
• 9.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Product

• 10.1 Market segments
• 10.2 Comparison by Product
• 10.3 Oligonucleotide products - Market size and forecast 2025-2030
• 10.4 Reagents and consumables - Market size and forecast 2025-2030
• 10.5 Synthesis equipment - Market size and forecast 2025-2030
• 10.6 Market opportunity by Product
  • Market opportunity by Product ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Thailand - Market size and forecast 2025-2030
  • 12.5.6 Indonesia - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 UAE - Market size and forecast 2025-2030
  • 12.6.3 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.4 Israel - Market size and forecast 2025-2030
  • 12.6.5 South Africa - Market size and forecast 2025-2030
  • 12.6.6 Turkey - Market size and forecast 2025-2030
  • 12.6.7 Argentina - Market size and forecast 2025-2030
  • 12.6.8 Colombia - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Technological advancements in oligonucleotide synthesis methods
  • Escalating demand for oligonucleotide-based therapeutics
  • Surging investments and strategic collaborations
• 13.2 Market challenges
  • High manufacturing costs and scalability limitations
  • Stringent regulatory requirements and compliance hurdles
  • Complexities in large-scale production and supply chain vulnerabilities
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Shift toward enzymatic and sustainable synthesis methods
  • Expansion of oligonucleotide applications in therapeutics and precision medicine
  • Increasing adoption of high-throughput and automated synthesis platforms

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Agilent Technologies Inc.
  • Agilent Technologies Inc. - Overview
  • Agilent Technologies Inc. - Business segments
  • Agilent Technologies Inc. - Key news
  • Agilent Technologies Inc. - Key offerings
  • Agilent Technologies Inc. - Segment focus
  • SWOT
• 15.5 Ajinomoto Bio Pharma Services
  • Ajinomoto Bio Pharma Services - Overview
  • Ajinomoto Bio Pharma Services - Product / Service
  • Ajinomoto Bio Pharma Services - Key offerings
  • SWOT
• 15.6 Ansa Biotechnologies
  • Ansa Biotechnologies - Overview
  • Ansa Biotechnologies - Product / Service
  • Ansa Biotechnologies - Key offerings
  • SWOT
• 15.7 Azenta Inc.
  • Azenta Inc. - Overview
  • Azenta Inc. - Business segments
  • Azenta Inc. - Key news
  • Azenta Inc. - Key offerings
  • Azenta Inc. - Segment focus
  • SWOT
• 15.8 Bio Synthesis Inc
  • Bio Synthesis Inc - Overview
  • Bio Synthesis Inc - Product / Service
  • Bio Synthesis Inc - Key offerings
  • SWOT
• 15.9 Biogen Inc.
  • Biogen Inc. - Overview
  • Biogen Inc. - Product / Service
  • Biogen Inc. - Key offerings
  • SWOT
• 15.10 Biotage AB
  • Biotage AB - Overview
  • Biotage AB - Product / Service
  • Biotage AB - Key offerings
  • SWOT
• 15.11 Danaher Corp.
  • Danaher Corp. - Overview
  • Danaher Corp. - Business segments
  • Danaher Corp. - Key news
  • Danaher Corp. - Key offerings
  • Danaher Corp. - Segment focus
  • SWOT
• 15.12 GenScript Biotech Corp.
  • GenScript Biotech Corp. - Overview
  • GenScript Biotech Corp. - Business segments
  • GenScript Biotech Corp. - Key offerings
  • GenScript Biotech Corp. - Segment focus
  • SWOT
• 15.13 Kaneka Corp.
  • Kaneka Corp. - Overview
  • Kaneka Corp. - Business segments
  • Kaneka Corp. - Key news
  • Kaneka Corp. - Key offerings
  • Kaneka Corp. - Segment focus
  • SWOT
• 15.14 Merck KGaA
  • Merck KGaA - Overview
  • Merck KGaA - Business segments
  • Merck KGaA - Key news
  • Merck KGaA - Key offerings
  • Merck KGaA - Segment focus
  • SWOT
• 15.15 Nitto Denko Corp.
  • Nitto Denko Corp. - Overview
  • Nitto Denko Corp. - Business segments
  • Nitto Denko Corp. - Key offerings
  • Nitto Denko Corp. - Segment focus
  • SWOT
• 15.16 QIAGEN N.V.
  • QIAGEN N.V. - Overview
  • QIAGEN N.V. - Product / Service
  • QIAGEN N.V. - Key news
  • QIAGEN N.V. - Key offerings
  • SWOT
• 15.17 Synbio Technologies LLC
  • Synbio Technologies LLC - Overview
  • Synbio Technologies LLC - Product / Service
  • Synbio Technologies LLC - Key offerings
  • SWOT
• 15.18 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations